Acyclovir

Product NDC: 50090-6335
11-digit product format: 500906335
Labeler code: 50090
Product ID: 50090-6335_d3a10247-e6a9-4247-b1cc-87092d2b6033
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA209366
Marketing category: ANDA
Marketing start: 2020-08-15
Substance: ACYCLOVIR
Active strength: 800 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A209366-001	ACYCLOVIR	ACYCLOVIR	400MG	TABLET / ORAL	AB		2019-10-07
A209366-002	ACYCLOVIR	ACYCLOVIR	800MG	TABLET / ORAL	AB		2019-10-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A209366-001	AB
A209366-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A209366-001	ACYCLOVIR	400MG	TABLET / ORAL	AB	2019-10-07	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A209366-002	ACYCLOVIR	800MG	TABLET / ORAL	AB	2019-10-07	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209366-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209366-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209366-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209366-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209366-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209366-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209366-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209366-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209366-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209366-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209366-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209366-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209366-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209366-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209366-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209366-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209366-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209366-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209366-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209366-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209366-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209366-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209366-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209366-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209366-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209366-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A209366-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A209366-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209366-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209366-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A209366-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A209366-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A209366-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A209366-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A209366-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A209366-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A209366-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A209366-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A209366-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A209366-002	AB	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Acyclovir
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ACYCLOVIR	800 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
X4HES1O11F	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197313	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
34a38cdf-04e8-4006-a9f5-4a0831117d61	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
33190c02-82e1-0a4d-d716-9ccd23588463	Product name	5	20250225
c367d1da-5a72-8966-6d11-1eb9a73ae758	Product name	3	20231115
5518bf13-db2f-2e9c-3679-e70ecf03752c	Product name	9	20210614
27897900-0e40-497b-97e1-88057e68fe6c	Product name	4	20200710
ca834e59-e669-229c-9288-0ccb76dc373e	Product name	9	20200220
d7f95c49-d3e1-4bbc-a389-e9cd73f59a28	Product name	1	20190702
fb15b394-3715-4c87-a447-421489aa8739	Product name	3	20170727
7bdc4804-3832-c0df-e519-72b6d47c9792	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50090-6335-0	Acyclovir	35 in 1 BOTTLE	TABLET	35	4
50090-6335-2	Acyclovir	70 in 1 BOTTLE	TABLET	70	4
50090-6335-3	Acyclovir	40 in 1 BOTTLE	TABLET	40	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-6335-0	EA - Each	50090-6335	fe805ef1-d3be-451d-81cd-e5bf39c09489	1	2023-03-13
50090-6335-2	EA - Each	50090-6335	f12a8b51-3943-4860-9f3e-279d83dddefd	1	2023-03-13
50090-6335-3	EA - Each	50090-6335	31cf942a-d3ed-4f0a-a477-76709bb7d9b1	1	2023-03-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-6335	ACYCLOVIR TABLET [A-S MEDICATION SOLUTIONS]	4	Current NDC, 3 package rows	20230208_34a38cdf-04e8-4006-a9f5-4a0831117d61.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Acyclovir	ACYCLOVIR	REMEDYREPACK INC.	37a51d9c-1f39-4065-8c7d-6528ac6de91c	2026-06-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	Preferred Pharmaceuticals Inc.	b1033fda-8242-4006-b1cd-23474d70671f	2026-01-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	REMEDYREPACK INC.	a1086845-ba08-4fb2-81dc-aea9c68bf2c3	2025-08-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	Direct_Rx	387d33ed-45e5-42d6-e063-6294a90afbb7	2025-06-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	Bryant Ranch Prepack	067109d0-2539-42b6-9e95-102b58ca54dc	2025-05-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	Bryant Ranch Prepack	713960c2-8278-4778-b781-08ec89a9cfce	2025-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	NuCare Pharmaceuticals,Inc.	116f4f0d-66c5-49dd-e063-6394a90ab2b5	2025-01-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	NuCare Pharmaceuticals,Inc.	e5e99a6b-79a6-7fdb-e053-2a95a90a8563	2024-12-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	Bryant Ranch Prepack	e73ae5c8-7a77-4330-817d-482d1de4e994	2024-04-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	Bionpharma Inc.	6f1db9f0-9b41-4fb7-8798-44fdc2c128df	2023-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	SQUARE PHARMACEUTICALS LIMITED	b24201ea-aeae-4de1-b01b-eee89068e786	2023-07-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366
Acyclovir	ACYCLOVIR	A-S Medication Solutions	34a38cdf-04e8-4006-a9f5-4a0831117d61	2023-02-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209366 application number: ANDA209366 ndc (product): 50090-6335

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197313	acyclovir 800 MG Oral Tablet	PSN	34a38cdf-04e8-4006-a9f5-4a0831117d61	4
197313	acyclovir 800 MG Oral Tablet	SCD	34a38cdf-04e8-4006-a9f5-4a0831117d61	4
197313	acycycloguanosine 800 MG Oral Tablet	SY	34a38cdf-04e8-4006-a9f5-4a0831117d61	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
50090-6335-0	50090633500	35 TABLET in 1 BOTTLE (50090-6335-0)	35 tablet	2023-01-18	No	No	Current
50090-6335-2	50090633502	70 TABLET in 1 BOTTLE (50090-6335-2)	70 tablet	2023-01-18	No	No	Current
50090-6335-3	50090633503	40 TABLET in 1 BOTTLE (50090-6335-3)	40 tablet	2023-01-18	No	No	Current